Analysis of MCL-1 Copy Number Variation in Non-Small Cell Lung Cancer

Authors

  • Almahdi Alzaroukh Jaber
  • Howard Pringle
  • David Guttery
  • Aesa Alzaroug Jaber

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15579

Keywords:

Non-small cell lung cancer, Amplification, Gain, MCL-1

Abstract

Amplification of the MCL-1 gene induces MCL-1 overexpression, which is an important marker for drug
resistance in several malignancies through evasion of apoptosis. We analysed 39 lung adenocarcinomas
(ADCs), 38 lung squamous cell carcinomas (SCCs), two large cell lung carcinomas (LCCs) and cell lines.
A duplex ratio test TaqMan qPCR approach was performed for MCL-1 copy number change analysis and
we demonstrated amplification of MCL-1 in H1395 cell line and copy number gain (isochromosome) in
H2342 cell line. Immunohistochemistry (IHC) and in situ hybridization (ISH) were performed for protein
and mRNA analysis respectively. MCL-1 amplification was detected in 13% and 2.5% of SCCs and ADCs
respectively. MCL-1-amplified tumours demonstrated high expression of MCL-1 mRNA. Copy number gain
was detected in 2.5 % of ADC but not SCC.

Author Biographies

  • Almahdi Alzaroukh Jaber

    Lecturer, Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, Tripoli University,
    Libya

  • Howard Pringle

    Expert Academic Pathologist, Department of Cancer Studies And Molecular Medicine, University of
    Leicester,

  • David Guttery

    Lecturer, Department of Cancer Studies And Molecular Medicine, University of Leicester

  • Aesa Alzaroug Jaber


    Assistant Professor, Department of Surgical Science, University of Science and Technology of Fujairah, UAE

Downloads

Published

2021-05-17

How to Cite

Analysis of MCL-1 Copy Number Variation in Non-Small Cell Lung Cancer. (2021). Indian Journal of Forensic Medicine & Toxicology, 15(3), 1812-1822. https://doi.org/10.37506/ijfmt.v15i3.15579